Yandex sold more than 52 million ordinary shares at $25 each compared to a planned $22 to $24 range, for an initial market cap of about $8bn before a 55% first day pop in its share price.

News provider International Financing Review (IFR) said the Beijing-based company could soon mandate banks on the initial public offering, which is planned for the final three months of the year.

Monsanto had bought 3.3 million shares in Ceres's E round last year at $6.50 per share following a $137m collaboration signed in 2002 applying genomics technologies to identify genes that provide improvements in corn, soybean and certain other row crops, according to its regulatory filing.

In March, Solazyme aimed to raise $100m but now said it would issue 11.5 million shares, including 1.5 million if demand is strong enough as a so-called greenshoe allotment, at between $15 and $17 each. At the top end of its pricing range, Solazyme would have an initial market capitalisation of $965m.

Fusion-io will issue 10.76 million shares with its owners selling 1.5 million at up to $15 each, before 1.85 million shares can be sold if demand is strong enough.

LinkedIn's shares closed at $94.25 each after the initial public offering of $45 per share and more than doubling its market capitalization to $8.9bn.

Investment banks and shareholders Morgan Stanley, Citigroup and Credit Suisse are underwriting Bats's initial public offering.

Softbank diluted to 34.2% after RenRen's initial public offering, having originally invested $100m in April 2008, according to data provider Zero2IPO. By December last year, Softbank had invested $315m to give a six times return on the book value of its holding at $14 per share, Zero2IPO added.